Clinical Trials Directory

Trials / Sponsors / Minervax ApS

Minervax ApS

Academic / Other · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingA Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Streptococcus Agalactiae Infection, Neonatal Sepsis, Pneumonia
Phase 2 / Phase 32025-03-07
Not Yet RecruitingGBS-NN/NN2 (50 µg of Each Fusion Protein [GBS-NN and GBS-NN2] in Combination With 500 µg Aluminum as Alhydroge
Streptococcus Agalactiae Infection
Phase 2 / Phase 32024-12-17
TerminatedA Follow up Study of Group B Streptococcus (GBS)-NN/NN2 Vaccine in Healthy Volunteers
Group B Streptococcus Infection
—2024-01-18
CompletedStudy to Evaluate the Safety, Tolerability and Immunogenicity of Three Doses of GBS Vaccine in Elderly Partici
Group B Streptococcal Infections
Phase 12023-03-01
CompletedImmunogenicity and Safety of GBS-NN/NN2 in Pregnant Women
Group B Streptococcal Infection
Phase 22022-02-17
CompletedStudy to Assess a Booster Dose of GBS-NN/NN2 Vaccine
Group B Streptococcus Infection
Phase 12021-08-17
CompletedStudy of a Group B Streptococcus Vaccine in Pregnant Women Living With HIV and in Pregnant Women Who do Not Ha
Group B Streptococcal Infection
Phase 22020-11-19
CompletedGroup B Streptococcus Vaccine in Healthy Females
Group B Strep Infection
Phase 12019-01-09
CompletedSafety and Immunogenicity of a Group B Streptococcus Vaccine in Non-pregnant Women 18-40 Years of Age.
Infection by Streptococcus Group B
Phase 12015-05-01